Dr. Pratik Sanjay Patil is a dedicated Oncologist with nearly a decade of experience in diagnosing and treating various forms of cancer. Since earning his MBBS from U. Karad in 2022, he has been actively involved in cancer diagnosis, treatment planning, and patient management. His expertise includes early cancer detection, chemotherapy, immunotherapy, and palliative care. Currently associated with All General Pathologist Centre in Satara, Maharashtra, Dr. Patil works closely with multidisciplinary teams to provide personalized treatment plans that improve patient survival rates and quality of life. His patient-first approach ensures that individuals receive the most advanced and compassionate cancer care available.
Krishna Institute of Medical Sciences, Karad · Bachelor of Medicine & Bachelor of Surgery (MBBS) · Year: 2022
Registration No. 2022062305 · Maharashtra Council of Indian Medicine · 2022
Medical registration details on file.
Dr. Patil has a keen interest in cancer research, particularly in tumor biology, targeted therapies, and advancements in oncology treatment protocols. His research focuses on early detection of malignancies, molecular oncology, and innovative treatment techniques like immunotherapy and gene therapy. He has contributed to studies analyzing the role of biomarkers in cancer diagnosis and the effectiveness of precision medicine in improving patient outcomes. His work aims to bridge the gap between cutting-edge research and real-world patient care, ensuring that oncology treatments continue to evolve and improve.
Dr. Pratik Sanjay Patil has made significant contributions to the field of oncology through his research and publications. His work primarily focuses on early cancer detection, targeted therapies, and advancements in modern oncology treatment. He has published research on advanced diagnostic techniques for identifying early-stage cancers, emphasizing the importance of histopathology, biomarkers, and molecular testing in improving survival rates.
Dr. Pratik Sanjay Patil has also explored the role of immunotherapy and targeted treatments in cancer care, analyzing how precision medicine can enhance patient outcomes and reduce side effects associated with conventional treatments. His contributions to oncology journals discuss innovations in chemotherapy, radiation therapy, and surgical oncology, helping to refine modern cancer treatment protocols.
Consultation fees are indicative and subject to change.
Consultation fees are indicative and subject to change.
The information on MyHospitalNow is for general informational purposes only and does not constitute medical advice. Consultation fees shown are indicative and subject to change. Always consult a qualified healthcare professional for diagnosis and treatment.